Categories: Stories

South African billionaire loses nearly US$1 billion but still has US$7 billion in cash

Patrick Soon-Shiong, a South African-born biopharma billionaire, has seen his net worth fall by more than US$956 million since the start of the year as investors continue to sell off shares in the biotech industry as part of a strategic move to preserve wealth and reduce exposure to risky assets.

According to data obtained by Billionaires.Africa from the Bloomberg Billionaires Index, his net worth has dropped from US$9.95 billion at the start of the year to US$8.99 billion, resulting in a US$956-million year-to-date loss for the billionaire.

The multimillion-dollar slump in his net worth can be attributed to a drop in the market value of his stake in ImmunityBio, a late-stage immunotherapy company that develops cell and immunological treatments for the treatment of cancer and infectious diseases.

Soon-Shiong, a South African-American transplant surgeon who was instrumental in the development of ImmunityBio, owns 73.2 percent of the biotech company.

Since the year began, the company’s shares have fallen by more than 48 percent, paring the triple-digit gains recorded in the early weeks of 2021 following the announcement of its merger with NantKwest, another Soon-Shiong company.

NantSA, NantKwest’s South African division, opened a plant in South Africa earlier this year with the goal of producing up to 1 billion COVID-19 vaccines per year by 2025, in line with Soon-Shiong’s plan to accelerate pharmaceutical, biological, and vaccine production for patients on the continent.

The factory, located in Cape Town, South Africa’s second-largest city, will be the first in Africa to produce COVID-19 vaccines from beginning to end. The plant’s commissioning will help Africa overcome its current position as the world’s least-vaccinated continent.

Despite its ambitions for African development, ImmunityBio’s shares have fallen by more than 48 percent this year, from US$7.53 to US$3.75 per share.

Soon-Shiong, who made his fortune by selling two drug companies for a total of US$7.4 billion in 2008 and 2010, was born in 1952 in South Africa to Chinese immigrant parents.

The billionaire has US$7.03 billion of his US$8.99-billion fortune in cash.- Billionaires.Africa

(267 VIEWS)

Charles Rukuni

The Insider is a political and business bulletin about Zimbabwe, edited by Charles Rukuni. Founded in 1990, it was a printed 12-page subscription only newsletter until 2003 when Zimbabwe's hyper-inflation made it impossible to continue printing.

Recent Posts

Britain says amendment of the Zimbabwean Constitution is a sovereign, legislative matter for Zimbabwe to decide

Britain says amendment of the Zimbabwe constitution is a sovereign, legislative matter for Zimbabwe to…

March 24, 2026

Who started the war?

It is now 47 years since I wrote the short story below for a South…

March 4, 2026

Zimbabwe 2026 monetary policy statement at a glance

Zimbabwe has released its 2026 monetary policy statement in which it seeks to stabilise its…

March 1, 2026

Was Chombo Mugabe’s number two?

Far from it, on paper that is. Ignatius Chombo was one of the longest serving…

February 6, 2026

Zimbabwe’s 2026 citizen’s budget

Zimbabwe on Thursday announced a ZiG290.9 billion budget with revenue expected to be ZiG287.6 billion,…

November 30, 2025

IMF says Zimbabwe’s economic recovery in 2025 is stronger than previously anticipated

The International Monetary Fund says Zimbabwe’s economic recovery in 2025 is stronger than previously anticipated…

November 8, 2025